ARCHIVES

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

USC $2.5 Million contract Tops Last Minute FY 75 Rush of Awards

July 18, 1975

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

May 5, 1995

Harold Varmus Nominated For NIH Director; Selection Wins Support of Biomedical Community

August 13, 1993

University of Wisconsin wins $7 million NIH construction grant for cancer center.

June 25, 2004

Cancer Groups Criticize FDA For Ignoring Expert Advice.

November 24, 2000

HRSA: Discounts Owed on Some Orphan Drug Uses

October 24, 2014